Park National Corp’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$17.5M Buy
14,574
+3,952
+37% +$4.04M 0.49% 58
2026
Q1
$9.77M Buy
10,622
+148
+1% +$150K 0.3% 85
2025
Q4
$11.3M Sell
10,474
-56
-0.5% -$53.5K 0.35% 71
2025
Q3
$8.03M Sell
10,530
-263
-2% -$196K 0.25% 81
2025
Q2
$8.41M Sell
10,793
-52
-0.5% -$40.4K 0.28% 78
2025
Q1
$8.96M Sell
10,845
-592
-5% -$493K 0.33% 76
2024
Q4
$8.83M Buy
11,437
+37
+0.3% +$30.6K 0.32% 70
2024
Q3
$10.1M Sell
11,400
-92
-0.8% -$82.7K 0.35% 71
2024
Q2
$10.4M Sell
11,492
-259
-2% -$207K 0.38% 64
2024
Q1
$9.14M Sell
11,751
-475
-4% -$338K 0.35% 67
2023
Q4
$7.13M Sell
12,226
-510
-4% -$298K 0.29% 80
2023
Q3
$6.84M Sell
12,736
-60
-0.5% -$30.9K 0.31% 74
2023
Q2
$6M Sell
12,796
-2,032
-14% -$852K 0.26% 81
2023
Q1
$5.09M Sell
14,828
-62
-0.4% -$20.9K 0.23% 86
2022
Q4
$5.45M Buy
14,890
+1,275
+9% +$452K 0.24% 86
2022
Q3
$4.4M Sell
13,615
-320
-2% -$101K 0.22% 88
2022
Q2
$4.52M Sell
13,935
-266
-2% -$79.8K 0.22% 89
2022
Q1
$4.07M Sell
14,201
-948
-6% -$244K 0.17% 97
2021
Q4
$4.18M Sell
15,149
-614
-4% -$156K 0.16% 95
2021
Q3
$3.64M Sell
15,763
-2,401
-13% -$593K 0.15% 96
2021
Q2
$4.17M Sell
18,164
-2,999
-14% -$602K 0.17% 91
2021
Q1
$3.95M Sell
21,163
-4,218
-17% -$825K 0.17% 90
2020
Q4
$4.29M Sell
25,381
-696
-3% -$104K 0.2% 85
2020
Q3
$3.86M Sell
26,077
-8,603
-25% -$1.33M 0.2% 85
2020
Q2
$5.69M Sell
34,680
-4,912
-12% -$754K 0.32% 76
2020
Q1
$5.49M Sell
39,592
-4,308
-10% -$592K 0.35% 69
2019
Q4
$5.77M Sell
43,900
-2,817
-6% -$327K 0.29% 73
2019
Q3
$5.22M Sell
46,717
-953
-2% -$106K 0.28% 75
2019
Q2
$5.28M Sell
47,670
-8,428
-15% -$992K 0.29% 72
2019
Q1
$7.28M Sell
56,098
-5,552
-9% -$675K 0.41% 54
2018
Q4
$7.13M Sell
61,650
-24,080
-28% -$2.69M 0.44% 52
2018
Q3
$9.2M Sell
85,730
-17,385
-17% -$1.74M 0.5% 47
2018
Q2
$8.8M Buy
103,115
+17,766
+21% +$1.46M 0.5% 46
2018
Q1
$6.6M Buy
85,349
+27,556
+48% +$2.22M 0.38% 57
2017
Q4
$4.88M Sell
57,793
-9,753
-14% -$830K 0.27% 68
2017
Q3
$5.78M Sell
67,546
-20,412
-23% -$1.67M 0.33% 59
2017
Q2
$7.24M Sell
87,958
-10,909
-11% -$890K 0.43% 55
2017
Q1
$8.32M Buy
98,867
+10,671
+12% +$855K 0.5% 49
2016
Q4
$6.49M Sell
88,196
-590
-0.7% -$43.9K 0.39% 56
2016
Q3
$7.13M Sell
88,786
-11,392
-11% -$912K 0.45% 56
2016
Q2
$7.89M Buy
100,178
+11,283
+13% +$849K 0.5% 51
2016
Q1
$6.4M Buy
88,895
+44,989
+102% +$3.4M 0.42% 55
2015
Q4
$3.7M Buy
43,906
+1,835
+4% +$152K 0.25% 68
2015
Q3
$3.52M Buy
42,071
+24,363
+138% +$2.06M 0.25% 69
2015
Q2
$1.48M Sell
17,708
-327
-2% -$24.9K 0.1% 119
2015
Q1
$1.31M Sell
18,035
-50
-0.3% -$3.56K 0.09% 125
2014
Q4
$1.25M Sell
18,085
-223
-1% -$15.1K 0.08% 124
2014
Q3
$1.19M Buy
18,308
+280
+2% +$17.7K 0.09% 122
2014
Q2
$1.12M Sell
18,028
-9,539
-35% -$569K 0.08% 127
2014
Q1
$1.62M Sell
27,567
-712
-3% -$39.7K 0.12% 104
2013
Q4
$1.44M Buy
28,279
+9,069
+47% +$454K 0.1% 110
2013
Q3
$967K Sell
19,210
-5,329
-22% -$279K 0.07% 135
2013
Q2
$1.21M Buy
+24,539
New +$1.34M 0.1% 119

Other funds holding LLY

Park National Corp's LLY Position: Q2 2026 in Review

Park National Corp increased its Eli Lilly (LLY) stake by 37% in Q2 2026, buying an estimated $4.04M and bringing the position to 14,574 shares worth $17.5M. The position accounts for 0.49% of the portfolio, ranked #58.

Park National Corp first reported a position in LLY in Q2 2013 and has held it in 53 quarters since. 2,115 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Park National Corp held 14,574 shares of Eli Lilly worth $17.5M as of Q2 2026.
  • Park National Corp bought 3,952 Eli Lilly shares in Q2 2026, an estimated $4.04M.
  • Eli Lilly made up 0.49% of Park National Corp's portfolio in Q2 2026, its #58 holding.
  • Park National Corp first reported a position in Eli Lilly in Q2 2013 and has held it in 53 quarters since.
  • 2,115 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Park National Corp's 13F filing for Q2 2026, filed 15 Jul 2026.